Answers are grounded in this paper and cite their sources.
HLA-DQA1*05 has been associated with anti-TNF immunogenicity, but evidence from Iraqi patients remains limited. We explored associations of HLA-DQA1*05 and HLA-DQA1*05/HLA-DQB1*02 co-carriage with anti-drug antibody (ADAb) concentrations, trough concentrations, and response during maintenance treatment. This single-center cross-sectional analysis included 80 adults receiving infliximab (n = 41) or adalimumab (n = 39). Serum anti-TNF trough concentrations and ADAb levels were measured using an enzyme-linked immunosorbent assay. Real-time PCR detection of both targets defined unphased co-carriage. Drug-specific models used log concentrations with HC3 robust inference or logistic regression for response, adjusting for current azathioprine use. There were 55 HLA-DQA1*05 carriers, 20 haplotype co-carriers, and 38 responders. No adjusted primary or secondary genetic comparison met the multiplicity-adjusted significance threshold. Adjusted response odds ratios for HLA-DQA1*05 carriers were 0.29 (95% CI 0.06–1.36, p = 0.115) for infliximab and 1.35 (0.34–5.32, p = 0.670) for adalimumab; haplotype co-carriage estimates were 1.24 (0.26–5.78, p = 0.787) for infliximab and 0.63 (0.15–2.73, p = 0.540) for adalimumab. Exploratory component analysis found CRP < 5 mg/L in 15/29 infliximab DQA1*05 carriers versus 12/12 non-carriers (p = 0.003; q = 0.024). Neither the HLA-DQA1*05 genotype nor the HLA-DQA1*05/HLA-DQB1*02 haplotype provides evidence of significant associations with ADAb concentrations, serum trough levels, or therapeutic response in either infliximab- or adalimumab-treated patients (all p > 0.05). In this Iraqi IBD cohort, interpretation of estimates regarding the association of the HLA-DQA1*05 genotype and the HLA-DQA1*05/HLA-DQB1*02 haplotype should be expressed cautiously, and clinically meaningful associations cannot be excluded.
No takes yet. Share an insight, caveat, or question.
Kanna et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: